The latest coronavirus stock screamers: Inovio Pharmaceuticals, Co-Diagnostics

The latest coronavirus stock screamers: Inovio Pharmaceuticals, Co-Diagnostics

Inovio gets a CEPI grant to develop a new coronavirus vaccine, Co-Diagnostics is readying a screening test if needed. As the coronavirus out of China spreads and gets deadlier, shares of health care companies that announce plans to take part in finding a vaccine, or identifying patients with the new strain, have rallied sharply in very active trading.. , which ran up 12% in afternoon trading, putting it on track for the highest close since May 9.. Trading volume swelled to 10.7 million shares, or more than seven times the full-day average over the past 30 days of about 1.4 million shares, according to FactSet.. The Pennsylvania-based biotechnology company said early Thursday that it was awarded a grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the new strain of coronavirus, 2019-nCoV, which originated in Wuhan, China, and has killed no less than 17 people.. The grant builds on Inovio's existing partnership with CEPI, in which the company was granted in April 2018 an award of up to $56 million to develop vaccines for Middle East Respiratory Syndrome (MERS) and Lassa fever.. The latest grant was aimed at